P. aeruginosa is widely found in the natural environment. It is highly tolerant and adaptable, able to survive in a variety of adverse environmental conditions such as low temperature, high temperature, high salinity, and acidic and alkaline environments. In the biomedical field, this kind of bacteria is a common pathogenic bacterium, especially in patients with depressed immune systems. It may cause a variety of infections, including respiratory tract infections, urinary tract infections, and wound infections. It is also a multi-drug-resistant bacterium that is resistant to a variety of antibiotics. It is also important in clinical and medical settings. The study of this bacterium will help to understand its pathogenic mechanisms, drug resistance mechanisms, and possible medical strategies to help medical professionals in related fields better prevent infections.
The P. aeruginosa polysaccharide antigen is of great importance in clinical diagnosis and vaccine development. Researchers are exploring its use to develop vaccines for the prevention and control of infections and diseases associated with this bacterium. CD BioGlyco offers P. aeruginosa polysaccharide antigens production service, including alginate, Pel, Psl, and LPS.
CD BioGlyco has established the state-of-the-art Glyco™ Vaccine Development Platform to provide customers with specialized Polysaccharide Antigen Production Services including P. Aeruginosa polysaccharide antigen production services. And we are capable of responding flexibly to our clients' requirements, providing fast delivery and high-quality products. Please feel free to contact us for more information.
Reference:
